Company & Sponsor Intelligence

Douglas Mental Health University Institute

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting1

Completed2

Countries1

Therapeutic footprint

alzheimersother_psychiatryschizophrenia

Indexed studies

NCT06893393Virtual Travel Into Nature for Individuals With Lived Experience of Severe Mental Disorders
other_psychiatry · CanadaNA

NCT06978894Predicting Psychotic Relapse Using Speech-Based Early Detection
schizophrenia · CanadaRECRUITING

NCT02702817Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia
alzheimers · CanadaPHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →